TTQ-SA
TTQ-SA is a near-infrared (NIR) spiro-AIEgen (aggregation-induced emission luminogen), that converts near-infrared light (NIR) into thermal energy, causing thermal damage and death of tumor cells. TTQ-SA exhibits cellular uptake and targeting ability in cancer cell MF-7. TTQ-SA silences the expression of survivin gene with combination of DNAzyme, enhances the sensitivity of tumor cells to photothermal therapy[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Photosensitizer
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
CC1(C)C2=C(C=CC=C2)N(C3=C4C=CC=C31)C5=C(C=CC=C5)C64C7=C(C=CC=C7)C(C(C8=C6C=CC=C8)=N9)=NC(C9=C(C%10=CC=C(N(C%11=CC=CC=C%11)C%12=CC=CC=C%12)C=C%10)C%13=NSN=C%13%14)=C%14C(C=C%15)=CC=C%15N(C%16=CC=CC=C%16)C%17=CC=CC=C%17
Molecular Formula
C78H53N7S
Molecular Weight
1120.37
References & Citations
[1]Chen Y, et al., Engineering a Near-Infrared Spiro-Based Aggregation-Induced Emission Luminogen for DNAzyme-Sensitized Photothermal Therapy with High Efficiency and Accuracy. J Am Chem Soc. 2024 Dec 25;146 (51) :35462-35477.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA378840 100 µL
myosin heavy chain 9 (MYH9) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC881390-100 1x 100 µL
CA19-9/Sialyl Lewisa (GI Tumor Marker) (CA19.9/1390R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details